How does a patient maximally benefit from anti-infective chemotherapy?

被引：13

作者：

Drusano, GL ^{[1
]}

机构：

[1] Ordway Res Inst, Albany, NY 12208 USA

来源：

CLINICAL INFECTIOUS DISEASES | 2004年 / 39卷 / 08期

关键词：

D O I：

10.1086/424673

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

引用

页码：1245 / 1246

页数：2

共 5 条

[1] In vivo pharmacokinetics and pharmacodynamics of a new triazole, voriconazole, in a murine candidiasis model [J].

Andes, D ;

Marchillo, K ;

Stamstad, T ;

Conklin, R .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2003, 47 (10) :3165-3169

[2] POPULATIONS AT RISK FOR PENICILLIN-INDUCED SEIZURES [J].

BARRONS, RW ;

MURRAY, KM ;

RICHEY, RM .

ANNALS OF PHARMACOTHERAPY, 1992, 26 (01) :26-29

[3] Adverse reactions to voriconazole [J].

Boyd, AE ;

Modi, S ;

Howard, SJ ;

Moore, CB ;

Keevil, BG ;

Denning, DW .

CLINICAL INFECTIOUS DISEASES, 2004, 39 (08) :1241-1244

[4] Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis [J].

Herbrecht, R ;

Denning, DW ;

Patterson, TF ;

Bennett, JE ;

Greene, RE ;

Oestmann, JW ;

Kern, WV ;

Marr, KA ;

Ribaud, P ;

Lortholary, O ;

Sylvester, R ;

Rubin, RH ;

Wingard, JR ;

Stark, P ;

Durand, C ;

Caillot, D ;

Thiel, E ;

Chandrasekar, PH ;

Hodges, MR ;

Schlamm, HT ;

Troke, PF ;

de Pauw, B .

NEW ENGLAND JOURNAL OF MEDICINE, 2002, 347 (06) :408-415

[5] Prospective evaluation of the effect of an aminoglycoside dosing regimen on rates of observed nephrotoxicity and ototoxicity [J].

Rybak, MJ ;

Abate, BJ ;

Kang, SL ;

Ruffing, MJ ;

Lerner, SA ;

Drusano, GL .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1999, 43 (07) :1549-1555

← 1 →